FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Enzo Biochem (NYSE: ENZ) reported Q2 EPS of $0.09, versus ($0.12) reported last year. Revenue for the quarter came in at $31.5 million, versus $19.4 million reported last year.
Dr. Elazar Rabbani, Founder and CEO, to step down as CEO and transition to a scientific... More
